Non-surgical periodontal therapy with adjunctive topical doxycycline: A double-masked, randomized, controlled multicenter study. II. Microbiological results

Journal of Periodontology

Volumn 76, Issue 1, 2005, Pages 66-74

  Ratka Krüger, Petra ^a,f   Schacher, Beate ^b   Bürklin, Thomas ^b   Böddinghaus, Boris ^b   Holle, Rolf ^c   Renggli, Heinz H ^d   Eickholz, Peter ^e   Kim, Ti Sun ^e  

^a UNIVERSITY OF FREIBURG   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^f UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Antibiotics therapeutic use; Doxycycline therapeutic use; Drug resistance; Follow up studies; Multicenter studies; Periodontal diseases therapy; RNA probes

Indexed keywords

AMOXICILLIN; CEFOXITIN; CLAVULANIC ACID; CLINDAMYCIN; DOXYCYCLINE; METRONIDAZOLE; PLACEBO;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; AGAR GEL DIFFUSION; AGED; ARTICLE; BIODEGRADABILITY; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG FORMULATION; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; MULTICENTER STUDY; PERIODONTAL DISEASE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PREVENTIVE DENTISTRY; RANDOMIZED CONTROLLED TRIAL; RNA PROBE; SAMPLE; TANNERELLA FORSYTHENSIS; TOOTH PLAQUE; TREATMENT OUTCOME; TREPONEMA DENTICOLA;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANTI-BACTERIAL AGENTS; DENTAL PLAQUE; DENTAL SCALING; DOUBLE-BLIND METHOD; DOXYCYCLINE; DRUG RESISTANCE, BACTERIAL; FEMALE; GELS; HUMANS; MALE; MIDDLE AGED; PERIODONTAL DISEASES; ROOT PLANING;

EID: 15944397576     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2005.76.1.66     Document Type: Article

References (65)

1. Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: Current concepts. J Periodontol 1992;63:322-331.
2. Zambon JJ. Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol 1985;12: 1-20.
3. Loesche WJ. The role of spirochetes in periodontal disease. Adv Dent Res 1988;2:275-283.
4. Dzink JL, Socransky SS, Haffajee AD. The predominant cultivable microbiota of active and inactive lesions of destructive periodontal diseases. J Clin Periodontol 1988; 15:316-323.
5. Slots J, Feik D, Rams TE. Actinobacillus actinomycetemcomitans and Bacteroides intermedius in human periodontitis: Age relationship and mutual association. J Clin Periodontol 1990;17:659-662.
6. Haffajee AD, Socransky SS. Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 1994; 5:78-111.
7. Dix K, Watanabe SM, Mc Ardle S, et al. Species-specific oligodeoxynucleotide probes for the identification of periodontal bacteria. J Clin Microbiol 1990;28:319-323.
8. Savitt ED, Keville MW, Peros WJ. DNA probes in the diagnosis of periodontal microorganisms. Arch Oral Biol 1990;35:153S-159S.
9. Mousquès T, Listgarten MA, Phillips RW. Effect of scaling and root planing on the composition of the human subgingival microbial flora. J Periodontal Res 1980;15:144-151.
10. Rosenberg ES, Evian CI, Listgarten MA. The composition of the subgingival microbiota after periodontal therapy. J Periodontol 1981;52:435-441.
11. Haffajee AD, Cugini MA, Dibart S, Smith C, Kent RL Jr, Socransky SS. The effect of SRP on the clinical and microbiological diseases. J Clin Periodontol 1997;24:324-334.
12. Ramfjord SP, Knowles JW, Nissle RR, Burgett FG, Shick RA. Results following three modalities of periodontal therapy. J Periodontol 1975;46:522-526.
13. Badersten A, Nilvéus R, Egelberg J. Effect of nonsurgical periodontal therapy. I. Moderately advanced periodontitis. J Clin Periodontol 1981;8:57-72.
14. Hill RW, Ramfjord SP, Morrison EC, et al. Four types of periodontal treatment compared over two years. J Periodontol 1981;52:655-662.
15. Pihlstrom BL, Ortiz-Campos C, McHugh RB. A randomized four-year study of periodontal therapy. J Periodontol 1981;52:227-242.
16. Badersten A, Nilvéus R, Egelberg J. Effect of nonsurgical periodontal therapy. II. Severely advanced periodontitis. J Clin Periodontol 1984;11:63-76.
17. Kaldahl WB, Kalkwarf KL, Patil KD, Dyer JK, Bates RE Jr. Evaluation of four modalities of periodontal therapy. Mean probing depth, probing attachment level and recession changes. J Periodontol 1988;59:783-793.
18. Rabbani GM, Ash MM, Caffesse RG. The effectiveness of subgingival scaling and root planing in calculus removal. J Periodontol 1981;52:119-123.
19. Caffesse RG, Sweeny PL, Smith BA. Scaling and root planing with and without periodontal flap surgery. J Clin Periodontol 1986;13:205-210.
20. Loos B, Claffey N, Egelberg J. Clinical and microbiological effects of root debridement in periodontal furcation pockets. J Clin Periodontol 1988;15:453-463.
21. Fleischer HC, Mellonig JT, Brayer WK, Gray, JL, Barnett JD. Scaling and root planing efficacy in multirooted teeth. J Periodontol 1989;60:402-409.
22. Adriaens PA, De Boever JA, Loesche WJ. Bacterial invasion in root cementum and radicular dentin of periodontally diseased teeth in humans. J Periodontol 1988;59: 222-230.
23. Danser MM, Timmermann MF, van Winkelhoff AJ, van der Velden U. The effect of periodontal treatment on periodontal bacteria on the oral mucous membranes. J Periodontol 1996;67:478-485.
24. Heijl L, Dahlen G, Sundin Y, Wenander A, Goodson JM. A 4-quadrant comparative study of periodontal treatment using tetracycyline-containing drug delivery fibers and scaling. J Clin Periodontol 1991;18:111-116.
25. Maiden MFJ, Tanner A, McArdle S, Najpauer K, Goodson JM. Tetracycline fiber therapy monitored by DNA probe and cultural methods. J Periodontal Res 1991;26:452-459.
26. Nakagawa T, Yamada S, Oosuka Y, et al. Clinical and microbiological study of local minocycline delivery (Periocline) following scaling and root planing in recurrent periodontal pockets. Bull Tokyo Dent Coll 1991;32:63-70.
27. Pedrazzoli V, Kilian M, Karring T. Comparative clinical and microbiological effects of topical subgingival application of metronidazole 25% dental gel and scaling in the treatment of adult periodontitis. J Clin Periodontol 1992; 19:715-722.
28. Walker CB, Godowski KC, Borden L, et al. The effects of sustained release doxycycline on the anaerobic flora and antibiotic-resistant patterns in subgingival plaque and saliva. J Periodontol 2000;71:768-774.
29. American Academy of Periodontology. The role of controlled drug delivery for periodontitis. J Periodontol 2000; 71:125-140.
30. Fiorellini JP, Paquette DW. The potential role of controlled-release delivery systems for chemotherapeutic agents in periodontics. Curr Opin Dent 1992;2:63-79.
31. Rapley JW, Cobb CM, Killoy WJ, Williams DR. Serum levels of tetracycline-containing fibers. J Periodontol 1992; 63:817-820.
32. Langer R, Peppas N. Present and future applications of biomaterials in controlled drug delivery systems. Biomaterials 1981;2:201-214.
33. Langer R. New methods of drug delivery. Science 1990; 249:1527-1533.
34. Rams TE, Keyes PH. A rationale for the management of periodontal diseases: Effects of tetracycline on subgingival bacteria. J Am Dent Assoc 1983;107:37-41.
35. Slots J, Rosling BG. Suppression of periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline. J Clin Periodontol 1983;10:465-486.
36. Novak MJ, Polson AM, Adair SM. Tetracycline therapy in patients with early juvenile periodontitis. J Periodontol 1988;59:366-372.
37. Mutschler E. Drug Activity. Textbook of Pharmacology and Toxicology (in German). Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH; 1996:679-682.
38. Sanz M, Herrera D. Individual drugs. In: Newman MG, van Winkelhoff AJ, eds. Antibiotic and Antimicrobial Use in Dental Practice, 2nd ed. Chicago: Quintessence Publishing Co., Inc.; 2001:33-52.
39. Greenstein G. Clinical significance of bacterial resistance to tetracyclines in the treatment of periodontal diseases. J Periodontol 1995;66:925-932.
40. Baker P, Evans R, Coburn R, Genco RJ. Tetracycline and its derivates strongly bind to and are released from the tooth surface in active form. J Periodontol 1983; 54:580-585.
41. Björvatn K, Skaug N, Selvig K. Inhibition of bacterial growth by tetracycline-impregnated enamel and dentin. Scand J Dent Res 1984;92:508-511.
42. Tonetti M, Cugini M, Goodson J. Zero-order delivery with periodontal placement of tetracycline loaded ethylene vinyl acetate fibers. J Periodontal Res 1990;25:243-249.
43. Demirel K, Baer PN, McNamara TF. Topical application of doxycycline on periodontally involved root surfaces in vitro: Comparative analysis of substantivity on cementum and dentin. J Periodontol 1991;62:312-316.
44. Eickholz P, Kim TS, Bürklin T, et al. Non-surgical periodontal therapy with adjunctive topical doxycyline: A double-blind randomized controlled multicenter study. I. Study design and clinical results. J Clin Periodontol 2002;29:108-117.
45. O'Leary TJ, Drake RB, Naylor JE. The plaque control record. J Periodontol 1972;43:38.
46. Löe H. The gingival index, the plaque index and the retention index system. J Periodontol 1967;38:610-616.
47. Rogall T, Wolters J, Flohr T, Bottger EC. Towards a phylogeny and definition of species at the molecular level within the genus Mycobacterium. Int J Syst Bacteriol 1990;40:323-330.
48. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. Ninth Informational Supplement. Wayne, PA: NCCLS; 1999. NCCLS document M100-S9.
49. Goodson JM, Haffajee A, Socransky SS. Periodontal therapy by local delivery of tetracycline. J Clin Periodontol 1979;6:83-92.
50. Goodson JM, Holborrow D, Dunn RL, Hogan PE, Dunham S. Monolithic tetracycline containing fibers for controlled delivery to periodontal pockets. J Periodontol 1983;54:575-579.
51. Goodson JM, Offenbacher S, Farr DH, Hogan PE. Periodontal disease treatment by local drug delivery. J Periodontol 1985;56:265-272.
52. Goodson JM, Tanner A, McArdle S, Dix K, Watanabe SM. Multicenter evaluation of tetracycline fiber therapy. III. Microbiological response. J Periodontal Res 1991;26:440-451.
53. Lowenguth RA, Chin I, Caton JG, et al. Evaluation of periodontal treatments using controlled-release tetracycline fibers: Microbiological response. J Periodontol 1995;66: 700-707.
54. van Steenberghe D, Bercy P, Kohl J, et al. Subgingival minocycline hydrochloride ointment in moderate to severe chronic adult periodontitis: A randomized, double-blind, vehicle-controlled, multi-center study. J Periodontol 1993;64:637-644.
55. Jones AA, Kornman KS, Newbold DA, Manwell MA. Clinical and microbiological effects of controlled-release locally delivered minocycline in periodontitis. J Periodontol 1994;65:1058-1066.
56. Stelzel M, Florès-de-Jacoby L. Topical metronidazole application compared with subgingival scaling. A clinical and microbiological study on recall patients. J Clin Periodontol 1996;23:23-29.
57. Rudhart A, Purucker P, Kage A, Hopfenmüller W, Bernimoulin JP. Local metronidazole application in maintenance patients. Clinical and microbiological evaluation. J Periodontol 1998;69:1148-1154.
58. Ainamo J, Lie T, Ellingsen BH, et al. Clinical responses to subgingival application of a metronidazole 25% gel compared to the effect of subginigival scaling in adult periodontitis. J Clin Periodontol 1992;19:723-729.
59. Garret S, Johnson L, Drisko CH, et al. Two multi-center studies evaluating locally delivered doxycycline hyclate, placebo control, oral hygiene, and scaling and root planing in the treatment of periodontitis. J Periodontol 1999; 70:490-503.
60. Quintiliani R Jr, Sahm DF, Courvalin P. Mechanisms of resistance to antimicrobial agents. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology. Washington DC: ASM Press; 1999: 1505-1525.
61. Roberts MC. Epidemiology of tetracycline-resistance determinants. Trends Microbiol 1994;10:353-357.
62. Simon C, Stille W. Therapeutical use of Antibiotics in Clinic and Practice (in German). Stuttgart, New York: Schattauer; 2000:165-171.
63. Goodson JM, Tanner A. Antibiotic resistance of the subgingival microbiota following local tetracycline therapy. Oral Microbiol Immunol 1992;7:113-117.
64. Larsen T. Occurrence of doxycycline resistant bacteria in the oral cavity after local administration of doxycycline in patients with periodontal disease. Scand J Infect Dis 1991;23:89-95.
65. Kim TS, Bürklin T, Schacher B, et al. Pharmacokinetic profile of a locally administered doxycycline gel in crevicular fluid, blood, and saliva. J Periodontol 2002;73: 1285-1291.